2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Ensysce Biosciences said its first tranche of a Series C Preferred Stock financing, totaling roughly $43 million, closed on August 7, 2026, raising more than $21 million in gross proceeds. The company believes this restores compliance with Nasdaq's minimum stockholders' equity requirement and that it qualifies for a second 180-day grace period to regain compliance with the $1.00 bid price rule.
First tranche closed August 7, 2026, raising more than $21 million gross; total financing is about $43 million for 120,260 Series C Preferred shares
Second tranche depends on a clinical trial milestone that has not yet occurred
Company believes stockholders' equity is at least $2.5 million, meeting the Nasdaq Rule 5550(b)(1) requirement, pending Nasdaq confirmation
Second 180-day bid price grace period was requested from Nasdaq on August 24, 2026; Nasdaq response is pending
Jupiter Neurosciences sold 307,692 shares at $6.50 each in a registered direct offering that closed August 24, 2026, for gross proceeds of about $2.0 million before fees and expenses. The company believes the sale brings its stockholders' equity above the $2.5 million Nasdaq continued-listing requirement, but it is still waiting for Nasdaq's formal confirmation, and its shares may face delisting if compliance is not shown at its next periodic report.
Shares issued: 307,692 common shares at $6.50 each, under an agreement dated August 21, 2026
Gross proceeds: approximately $2.0 million before placement agent fees and offering expenses, closed August 24, 2026
Nasdaq stockholders' equity requirement: $2.5 million; company awaiting formal determination of compliance
Delisting risk remains if compliance is not evidenced at the next periodic report
At its recessed annual meeting on August 21, 2026, New Concept Energy stockholders approved issuing 2,000,000 new common shares to Realty Advisors, Inc. (RAI) for $1.00 per share in cash, or $2,000,000 in total. The issuance will proceed only after the NYSE American approves the additional listing application, and the filing states that it will cause a change in control, with RAI owning about 33.65% of outstanding shares afterward.
Stockholders approved the issuance with 1,872,051 votes for, 128,492 against and 120 abstentions.
RAI will pay $1.00 per share, $2,000,000 in total, from its working capital once the NYSE American approves the listing.
After the issuance RAI would hold 2,400,000 of 7,131,935 outstanding shares, about 33.65%, versus 400,000 shares (7.79%) it holds now.
NAPCO Security Technologies reported fiscal fourth-quarter and full-year 2026 results for the period ended June 30, 2026. Fourth-quarter revenue and net income reached records, while full-year net income slipped 0.9% after a $16 million litigation settlement charge in the third quarter. The board also declared a quarterly dividend of $0.17 per share, an increase of 13.3%.
Q4 net income rose 52.7% to a record $17.8 million; diluted EPS was $0.50, including about $0.09 from net tariff refunds.
Full-year net income fell 0.9% to $43.0 million, while diluted EPS rose 0.8% to $1.20 and non-GAAP diluted EPS was $1.60.
Full-year net revenue rose 11.4% to a record $202.3 million; recurring service revenue rose 13.0% to $97.5 million.
Quarterly dividend increased 13.3% to $0.17 per share, payable October 2, 2026, to holders of record September 11, 2026.
Expion Energy closed a $9.0 million private placement of 8% convertible debentures, with about $8.2 million in expected net proceeds, and acquired oil and gas assets in Eastern Louisiana for an adjusted cash price of $3,425,000. Kevin Sellers replaced Joseph Hammer as chief executive effective August 24, 2026, and the lead investor is affiliated with Hammer, who remains interim chairman. The financing is convertible into preferred stock and warrants, which could dilute shareholders, and the company is shifting into a new business line.
$9.0 million 8% convertible debentures due August 21, 2029, with net proceeds of about $8.2 million; conversion into Series A-1 preferred requires shareholder approval, with an initial conversion price of $4.25 per share.
Warrants to purchase up to 2,117,219 common shares; investors may buy up to $91.0 million of additional convertible preferred stock, subject to shareholder approval.
Acquired Eastern Louisiana oil and gas assets for an adjusted cash price of $3,425,000; the exploration agreement commits up to $4,000,000 to leasing and calls for a new lateral wellbore by February 15, 2027.
Kevin Sellers named CEO and board member effective August 24, 2026; lead purchaser Five Narrow Lane LP is affiliated with Joseph Hammer, who stepped down as CEO and remains interim chairman.
Azenta's President and CEO John Marotta resigned from the company and its Board effective August 22, 2026, and the Board named director Dr. Martin Madaus as interim President and CEO. The company reaffirmed its fourth quarter fiscal 2026 total revenue guidance but expects a one-time approximately $3 million consulting expense to affect fourth quarter adjusted EBITDA, and a search for a permanent CEO is underway.
John P. Marotta resigned as President, CEO and director effective August 22, 2026; the company says the resignation was not due to any disagreement on operations, policies or practices.
Dr. Martin D. Madaus, a Board member since January 2024, was elected interim President and CEO effective August 22, 2026, and will step down from the Nominating and Governance Committee chair role.
Fourth quarter fiscal 2026 total revenue guidance, issued August 4, 2026, was reaffirmed; adjusted EBITDA will be affected by a one-time approximately $3 million consulting expense.
The Board reduced its size from nine to eight members, and the company has retained Heidrick & Struggles to search for a permanent CEO.
RUM Group's affiliate signed a six-year commercial agreement with an unaffiliated U.S. cloud customer to supply GPU services at the company's Maysville, GA site, which is still under development, with a total order value of approximately $13.7 billion. In connection with the deal, the company entered a binding term sheet to issue the customer a warrant for up to 50,808,408 Class A shares at $0.01 per share, which creates potential dilution for existing shareholders, and the company disclosed that it does not currently have financing for the required spending.
Customer will buy GPU services in three tranches with a total order value of approximately $13.7 billion; the third tranche requires the customer's approval of the proposed delivery date.
Warrant covers up to 50,808,408 Class A shares at $0.01 per share; the initial 50% vests in three 16.67% tranches tied to the customer's purchases.
The remaining 50% of warrant shares can vest in five 10% tranches only if the customer signs one or more expansion agreements.
The company has no current financing for the project, and its obligations under the commercial agreement are not subject to any financing condition.
A federal court in California ruled in several related cases involving Sable's Santa Ynez Pipeline System. The court found Sable violated the 2020 consent decree by restarting operations without state authorization, imposed a $1.449 million penalty, and declined to order a shutdown because the federal pipeline regulator PHMSA had approved the Restart Plan. The court also denied California's bid for a preliminary injunction against the federal Defense Production Act order, and California filed a notice of appeal on August 20, 2026.
Court found Sable violated the Consent Decree by restarting the onshore pipeline without OSFM authorization, but declined to order a shutdown.
Court imposed a $1.449 million penalty on the Company.
Court denied California's motion for a preliminary injunction against the DPA Order; California filed notice of appeal on August 20, 2026.
In a separate case, the court declared the DPA Order bars California Department of Parks and Recreation from suing to stop Sable's onshore operations; defendant filed notice of appeal on August 21, 2026.
On August 21, 2026, a Delaware federal jury returned a verdict in patent infringement action brought by Beckman Coulter against Cytek Biosciences. The jury found noninfringement and invalidity on three of four asserted claims, but found infringement under the doctrine of equivalents on one claim and awarded $20 million in lost profits and $36.11 million in royalties. The company plans post-verdict motions and may appeal, and says the verdict does not require changes to its current products or operations.
Jury found noninfringement and invalidity on three of the four asserted patent claims.
On the remaining claim, jury found no literal infringement but found infringement under the doctrine of equivalents.
Past damages awarded: $20 million in lost profits and $36.11 million in royalties.
Company intends to pursue post-verdict motions and may appeal to the Federal Circuit; it says its products remain available.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.